Cargando…
Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy
BACKGROUND: To study the interaction between idiopathic macular telangiectasis type 2 (MacTel2) and coexistent diabetic retinopathy (DR) during long term follow up. METHODS: A retrospective chart review was done for all eyes with MacTel2 and DR with a minimum 2 years follow up. Eyes with other retin...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742487/ https://www.ncbi.nlm.nih.gov/pubmed/29299346 http://dx.doi.org/10.1186/s40942-017-0103-x |
_version_ | 1783288386710142976 |
---|---|
author | Jhingan, Mahima Marsonia, Kerul Shukla, Dhananjay Rosenfeld, Philip J. Chhablani, Jay |
author_facet | Jhingan, Mahima Marsonia, Kerul Shukla, Dhananjay Rosenfeld, Philip J. Chhablani, Jay |
author_sort | Jhingan, Mahima |
collection | PubMed |
description | BACKGROUND: To study the interaction between idiopathic macular telangiectasis type 2 (MacTel2) and coexistent diabetic retinopathy (DR) during long term follow up. METHODS: A retrospective chart review was done for all eyes with MacTel2 and DR with a minimum 2 years follow up. Eyes with other retinal disorders and poor quality imaging were excluded. Data collected included demographics, presenting visual acuity, systemic evaluation, treatments done, duration of follow up, and final visual outcomes. RESULTS: Out of 951 patients with MacTel2, 277 patients had diabetes. Out of 277 patients, 44 eyes of 22 patients had MacTel2 coexisting with DR. Twenty-eight eyes of 14 patients were included in this study. All cases of MacTel2 were bilateral with a preponderance of women (71.42%). Mean follow up was 93.07 ± 84.03 months with a mean random blood sugar level of 135.41 ± 45.47 mg% at presentation. Twenty-five (89.28%) eyes presented with mild non-proliferative diabetic retinopathy. Two (7.14%) eyes progressed in their DR staging from baseline. Stage III MacTel2 were noted in 11 (39.28)% eyes at baseline. None of these eyes progressed to stage V during follow up. Mean presenting logMAR BCVA was 0.214 ± 0.227 which dropped to 0.399 ± 0.301 at last visit (p = 0.0005). Diabetic macula edema (DME) was not noted in any eye till last follow up. CONCLUSIONS: 12.5% of eyes with MacTel2 in diabetic patients had coexistent DR. MacTel2 led to slowly progressive visual loss irrespective of the presence of DR. |
format | Online Article Text |
id | pubmed-5742487 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57424872018-01-03 Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy Jhingan, Mahima Marsonia, Kerul Shukla, Dhananjay Rosenfeld, Philip J. Chhablani, Jay Int J Retina Vitreous Original Article BACKGROUND: To study the interaction between idiopathic macular telangiectasis type 2 (MacTel2) and coexistent diabetic retinopathy (DR) during long term follow up. METHODS: A retrospective chart review was done for all eyes with MacTel2 and DR with a minimum 2 years follow up. Eyes with other retinal disorders and poor quality imaging were excluded. Data collected included demographics, presenting visual acuity, systemic evaluation, treatments done, duration of follow up, and final visual outcomes. RESULTS: Out of 951 patients with MacTel2, 277 patients had diabetes. Out of 277 patients, 44 eyes of 22 patients had MacTel2 coexisting with DR. Twenty-eight eyes of 14 patients were included in this study. All cases of MacTel2 were bilateral with a preponderance of women (71.42%). Mean follow up was 93.07 ± 84.03 months with a mean random blood sugar level of 135.41 ± 45.47 mg% at presentation. Twenty-five (89.28%) eyes presented with mild non-proliferative diabetic retinopathy. Two (7.14%) eyes progressed in their DR staging from baseline. Stage III MacTel2 were noted in 11 (39.28)% eyes at baseline. None of these eyes progressed to stage V during follow up. Mean presenting logMAR BCVA was 0.214 ± 0.227 which dropped to 0.399 ± 0.301 at last visit (p = 0.0005). Diabetic macula edema (DME) was not noted in any eye till last follow up. CONCLUSIONS: 12.5% of eyes with MacTel2 in diabetic patients had coexistent DR. MacTel2 led to slowly progressive visual loss irrespective of the presence of DR. BioMed Central 2017-12-25 /pmc/articles/PMC5742487/ /pubmed/29299346 http://dx.doi.org/10.1186/s40942-017-0103-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Original Article Jhingan, Mahima Marsonia, Kerul Shukla, Dhananjay Rosenfeld, Philip J. Chhablani, Jay Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
title | Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
title_full | Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
title_fullStr | Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
title_full_unstemmed | Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
title_short | Idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
title_sort | idiopathic macular telangiectasis type 2 and co-existent diabetic retinopathy |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742487/ https://www.ncbi.nlm.nih.gov/pubmed/29299346 http://dx.doi.org/10.1186/s40942-017-0103-x |
work_keys_str_mv | AT jhinganmahima idiopathicmaculartelangiectasistype2andcoexistentdiabeticretinopathy AT marsoniakerul idiopathicmaculartelangiectasistype2andcoexistentdiabeticretinopathy AT shukladhananjay idiopathicmaculartelangiectasistype2andcoexistentdiabeticretinopathy AT rosenfeldphilipj idiopathicmaculartelangiectasistype2andcoexistentdiabeticretinopathy AT chhablanijay idiopathicmaculartelangiectasistype2andcoexistentdiabeticretinopathy |